141 related articles for article (PubMed ID: 1840093)
1. Radiotoxicity of 5-[125I]iodo-2'-deoxyuridine in mammalian cells following treatment with 5-fluoro-2'-deoxyuridine.
Kassis AI; Guptill WE; Taube RA; Adelstein SJ
J Nucl Biol Med (1991); 1991; 35(3):167-73. PubMed ID: 1840093
[TBL] [Abstract][Full Text] [Related]
2. Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine.
Makrigiorgos GM; Kassis AI; Baranowska-Kortylewicz J; McElvany KD; Welch MJ; Sastry KS; Adelstein SJ
Radiat Res; 1989 Jun; 118(3):532-44. PubMed ID: 2727274
[TBL] [Abstract][Full Text] [Related]
3. Radiotoxicity of 125I in mammalian cells.
Kassis AI; Fayad F; Kinsey BM; Sastry KS; Taube RA; Adelstein SJ
Radiat Res; 1987 Aug; 111(2):305-18. PubMed ID: 3628718
[TBL] [Abstract][Full Text] [Related]
4. 5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats.
Kassis AI; Wen PY; Van den Abbeele AD; Baranowska-Kortylewicz J; Makrigiorgos GM; Metz KR; Matalka KZ; Cook CU; Sahu SK; Black PM; Adelstein SJ
J Nucl Med; 1998 Jul; 39(7):1148-54. PubMed ID: 9669385
[TBL] [Abstract][Full Text] [Related]
5. Radiotoxicity of an 125I-labeled DNA intercalator in mammalian cells.
Kassis AI; Fayad F; Kinsey BM; Sastry KS; Adelstein SJ
Radiat Res; 1989 May; 118(2):283-94. PubMed ID: 2727257
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of uptake, retention, and radiotoxicity of 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes.
Kassis AI; Sastry KS; Adelstein SJ
Radiat Res; 1987 Jan; 109(1):78-89. PubMed ID: 3809393
[TBL] [Abstract][Full Text] [Related]
7. Survival and DNA damage in Chinese hamster V79 cells exposed to alpha particles emitted by DNA-incorporated astatine-211.
Walicka MA; Vaidyanathan G; Zalutsky MR; Adelstein SJ; Kassis AI
Radiat Res; 1998 Sep; 150(3):263-8. PubMed ID: 9728654
[TBL] [Abstract][Full Text] [Related]
8. Chemical modification of 5-[125I]iodo-2'-deoxyuridine toxicity in mammalian cells in vitro.
Walicka MA; Adelstein SJ; Kassis AI
Int J Radiat Biol; 2001 May; 77(5):625-30. PubMed ID: 11382341
[TBL] [Abstract][Full Text] [Related]
9. Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: clonogenic survival.
Walicka MA; Adelstein SJ; Kassis AI
Radiat Res; 1998 Feb; 149(2):142-6. PubMed ID: 9457893
[TBL] [Abstract][Full Text] [Related]
10. The toxicity of fluorodeoxyuridine when used to increase the uptake of 125I-iododeoxyuridine into tissue culture cells in vitro.
Holmes JM
J Comp Pathol; 1983 Oct; 93(4):531-9. PubMed ID: 6227637
[TBL] [Abstract][Full Text] [Related]
11. On the safety of 5-[125I]iodo-2'-deoxyuridine--Preclinical evaluation in swine.
Baranowska-Kortylewicz J; Dalrymple GV; Harrison KA; Holdeman KP; Sharp JG; Cohen SM; Lieberman RP; Schneiderman MH; Clausen SR; Hoffman D; Lai J; Schneiderman GS; Helseth L
Acta Oncol; 1996; 35(7):925-33. PubMed ID: 9004773
[TBL] [Abstract][Full Text] [Related]
12. The effect of 125I-5-iodo-2'-deoxyuridine labelling on murine tumour cells.
Bishop CJ; Sheridan JW; Donald KJ
Br J Exp Pathol; 1981 Feb; 62(1):22-6. PubMed ID: 6784742
[TBL] [Abstract][Full Text] [Related]
13. Selective uptake of toxic nucleoside (125IUdR) by resistant cancer.
Bagshawe KD; Sharma K; Southall PJ; Boden JA; Boxer GM; Patridge TA; Antoniw P; Pedley RB
Br J Radiol; 1991 Jan; 64(757):37-44. PubMed ID: 1998836
[TBL] [Abstract][Full Text] [Related]
14. Inhomogeneity of the nucleus to 125IUdR cytotoxicity.
Yasui LS; Hofer KG; Warters RL
Radiat Res; 1985 Apr; 102(1):106-18. PubMed ID: 3920724
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic and lethal effects of [5-125I]iodo-2'-deoxyuridine incorporated into DNA of mammalian cells, and their RBEs.
Miyazaki N; Fujiwara Y
Radiat Res; 1981 Dec; 88(3):456-65. PubMed ID: 7313075
[No Abstract] [Full Text] [Related]
16. In vivo therapy of neoplastic meningitis with methotrexate and 5.
Kassis AI; Dahman BA; Adelstein SJ
Acta Oncol; 2000; 39(6):731-7. PubMed ID: 11130012
[TBL] [Abstract][Full Text] [Related]
17. Tumor targeting potential and metabolism of 5-[125I]iodo-2'-deoxyuridine injected intratumorally in patients with breast cancer.
Mariani G; Collecchi P; Giuliani L; Baranowska-Kortylewicz J; Di Luca L; Meucci G; Viacava P; Van den Abbeele AD; Salvadori PA; Di Sacco S
Ann N Y Acad Sci; 1993 Nov; 698():204-11. PubMed ID: 8279758
[TBL] [Abstract][Full Text] [Related]
18. The potentiation by 5-iodo-2'-deoxyuridine (IUDR) of the tumor-inhibitory activity of 5-fluoro-2'-deoxyuridine (FUDR).
HEIDELBERGER C; GRIESBACH L; GHOBAR A
Cancer Chemother Rep; 1960 Feb; 6():37-8. PubMed ID: 14400595
[No Abstract] [Full Text] [Related]
19. Cell survival and cytogenetic responses to 125I-UdR in cultured mammalian cells.
Chan PC; Lisco E; Lisco H; Adelstein SJ
Curr Top Radiat Res Q; 1978 Jan; 12(1-4):426-35. PubMed ID: 565273
[TBL] [Abstract][Full Text] [Related]
20. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'- deoxyuridine after intravesical infusion in patients with bladder cancer.
Mariani G; Collecchi P; Baldassarri S; Di Luca L; Buralli S; Fontanini G; Baranowska-Kortylewicz J; Adelstein SJ; Kassis AI
J Nucl Med; 1996 Apr; 37(4 Suppl):16S-19S. PubMed ID: 8676197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
